NCT00665275

Brief Summary

This is an observational study aiming to study the use of complementary and alternative medicine (CAM) drugs and methods among patients with inflammatory rheumatic diseases, at Rheumatology clinics in western Sweden and also to investigate possible associations between CAM using habits and other characteristics of the patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2007

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 23, 2008

Completed
Last Updated

April 23, 2008

Status Verified

April 1, 2008

Enrollment Period

4 months

First QC Date

April 18, 2008

Last Update Submit

April 18, 2008

Conditions

Rheumatic Diseases

Keywords

complementaryalternativemedicine

Outcome Measures

Primary Outcomes (1)

  • The prevalence of complementary and alternative medicine (CAM) drugs and methods among patients with inflammatory rheumatic diseases in western Sweden.

    July 2007

Secondary Outcomes (1)

  • To investigate potential significant associations between CAM using habits and characteristics of the patients.

    July 2007

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Lists of outpatients who were scheduled for appointments at the rheumatology clinic were sent to an external randomizer, to randomly elect patients who were asked to participate. Patients were eligible for inclusion if they were attending the rheumatology clinic and had had an appointment there before. Patients were excluded if they were on their first visit to the practice, had dementia or had difficulties understanding Swedish.

You may not qualify if:

  • Patients were excluded if they were on their first visit to the practice, had dementia or had difficulties understanding Swedish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rheumatology, Sahlgrenska University Hospital

Gothenburg, S-413 46, Sweden

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum

MeSH Terms

Conditions

Rheumatic Diseases

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Helena Forsblad d'Elia, MD, PhD

    Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 18, 2008

First Posted

April 23, 2008

Study Start

March 1, 2007

Primary Completion

July 1, 2007

Study Completion

July 1, 2007

Last Updated

April 23, 2008

Record last verified: 2008-04

Locations

SE(1)